Citadel Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,843,112
| Closed | -$2.3M | – | 7526 |
|
|
2022
Q1 | $2.3M | Buy |
1,843,112
+47,617
| +3% | +$59.5K | ﹤0.01% | 2859 |
|
|
2021
Q4 | $2.08M | Sell |
1,795,495
-58,331
| -3% | -$67.7K | ﹤0.01% | 3014 |
|
|
2021
Q3 | $3.56M | Sell |
1,853,826
-18,410
| -1% | -$35.4K | ﹤0.01% | 2375 |
|
|
2021
Q2 | $4.38M | Buy |
1,872,236
+41,450
| +2% | +$97K | ﹤0.01% | 2312 |
|
|
2021
Q1 | $4.96M | Buy |
1,830,786
+22,054
| +1% | +$59.8K | ﹤0.01% | 2112 |
|
|
2020
Q4 | $4.38M | Buy |
1,808,732
+10,729
| +0.6% | +$26K | ﹤0.01% | 1880 |
|
|
2020
Q3 | $4.12M | Buy |
1,798,003
+1,758,244
| +4,422% | +$4.03M | ﹤0.01% | 1649 |
|
|
2020
Q2 | $92K | Buy |
39,759
+18,846
| +90% | +$43.6K | ﹤0.01% | 4259 |
|
|
2020
Q1 | $36K | Sell |
20,913
-29,442
| -58% | -$50.7K | ﹤0.01% | 4587 |
|
|
2019
Q4 | $104K | Buy |
50,355
+35,882
| +248% | +$74.1K | ﹤0.01% | 4281 |
|
|
2019
Q3 | $42K | Sell |
14,473
-2,817
| -16% | -$8.18K | ﹤0.01% | 4389 |
|
|
2019
Q2 | $68K | Buy |
+17,290
| New | +$68K | ﹤0.01% | 4315 |
|
|
2019
Q1 | – | Sell |
-4,989
| Closed | -$11K | – | 5316 |
|
|
2018
Q4 | $11K | Buy |
+4,989
| New | +$11K | ﹤0.01% | 4403 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4974 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4794 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4650 |
|
|
2017
Q4 | – | Sell |
-2,778
| Closed | -$32K | – | 4484 |
|
|
2017
Q3 | $32K | Buy |
2,778
+1,405
| +102% | +$16.2K | ﹤0.01% | 3458 |
|
|
2017
Q2 | $57K | Buy |
+1,373
| New | +$57K | ﹤0.01% | 3379 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4413 |
|